Baidehi Maiti, Medical Oncologist and Hematologist at the Cleveland Clinic Fairview Hospital, shared a post on LinkedIn:
“So excited to share the publication of our study.
The association of cardiometabolic comorbidities with poorer survival despite preserved pCR in early stage TNBC patients treated with the KEYNOTE-522 regimen, indicates that in addition to highly effective treatment options, systematic cardiometabolic assessment and proactive management are essential to improve patient outcomes.
Congratulations to Jasmin Hundal and all the co-authors for this amazing work!”
Title: Impact of cardiometabolic health on treatment outcomes in early-stage triple-negative breast cancer receiving chemoimmunotherapy
Authors: Jasmin Hundal, Asfand Cheema, Akram Abushamma, Kirti Arora, Xiaoying Chen, Kelly Fargo, Maiti Baidehi
Read the Full Article.
